BioSpace
Avsnitt

Fibrosis, IPF and the search for better therapies

BioSpace
Dela

In this episode of Denatured, you'll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder & Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpacking treatment hurdles, emerging targets, unmet needs and expansion paths beyond the lung.

Host

Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Georg Vo Beiske, CEO, Tribune Therapeutics

Jonas Hallén, Co-Founder & CMO, Calluna Pharma

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör BioSpace. Innehållet i podden är skapat av BioSpace och inte av, eller tillsammans med, Poddtoppen.